CatalystFDA/Bio

Aprea Advances APR-1051; Phase 1 Enrollment Accelerates

APR-1051 Phase 1 enrollment acceleration signals key clinical catalyst for biotech investors.

What changed

APR-1051 Phase 1 enrollment acceleration signals key clinical catalyst for biotech investors.

Why it matters

APR-1051 Phase 1 enrollment acceleration signals key clinical catalyst for biotech investors. — impact context not separately stored; see What changed.

Sources

eodhd